DeviceTalks Podcast Network

DeviceTalks Podcast Network

By DeviceTalks Podcast NetworkNewsHealth & FitnessTechnologyTech News
Download on the App Store

All DeviceTalks Podcast Network episodes

  • Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
    First, a quick recap of DeviceTalks Boston. Then, a MedtronicTalks Podcast Replay, in which Austin L. Chiang, MD, explains why he brought his sizable social media following to Medtronic, where he serves as chief medical officer of the Gastrointestinal business. Chiang says his decision is directly tied to his excitement about Medtronic’s growing suite of GI products including the AI-powered GI Genius and the swallowable PillCam. Chiang explains why he chose to couple the company’s broad platform with his own social media presence to reach more patients who may need treatment of gastrointestinal care. He also gives advice to other physicians who may want to amplify their own voices through social media.
    38 min
  • DTW- What’s coming up at DeviceTalks Boston? A DTW contest! Also, can Fictiv fix the supply chain?
    DeviceTalks Boston is here! Win a free registration.
    In this week’s episode, we’ll give you a little taste of what you’ll see at the Boston Convention & Exhibition Center on May 10-11. Friend and colleague Steve Crowe, editorial director of the Healthcare Robotics Engineering Forum, will share what attendees will see at that meeting, which is co-located with DeviceTalks Boston.
    Then, we’ll talk with Peter Stebbins about his Opening Keynote Interview with medtech veteran Peter Doyle, who is now dean of Harvard John A. Paulson School of Engineering and Applied Sciences.
    We’ll also get a final update from Paul Grand, CEO of Medtech Innovator, about the 22 mid-stage medical device companies that will be presenting at DeviceTalks Boston. A selected few will then compete at Medtech Innovator’s Pitch Contest on May 11.
    And to demonstrate we’re not just selling you on an event, we talk with Dave Evans, co-founder and CEO of Fictiv, a technology company that has raised nearly $200 million to fix – or disrupt – the supply chain.
    Finally, a contest for loyal and attentive DeviceTalks Weekly Podcast listeners. Win free registration to DeviceTalks Boston!
    55 min
  • DTW – How Baylis fits into Boston Scientific’s EP portfolio; also putting Medtech’s story to music
    In this episode, Nick Spadea-Anello, Boston Scientific’s global president of electrophysiology, will explain how the $1.7 billion paid for Baylis Medical will help expand the Boston's extensive EP portfolio. We also talk about the message he likes to impart upon employees of recently acquired companies, sharing some lessons he learned when Boston Scientific acquired his then-employer, Guidant.
    We also welcome Brian Johnson, president of MassMedic, the top medical device association in New England, into the booth as our co-host.
    Johnson, of course, brings his insider perspective to Newmarker’s Newsmakers, but he also shares how everyone needs to do a better job of sharing medtech’s stories. He should know. Johnson is the co-founder of MassDevice and DeviceTalks! So we got an origin story as well.
    Executive editor Chris Newmarker brought a powerful newsmaker list including an interesting take on a recent collaboration between Medtronic and GE Healthcare. Other newsmakers include Alcon, Philips, Abbott, and the deal between Medtronic and Acutus medical that might be an answer to Boston’s acquisition of Bayliss.
    5 - https://www.massdevice.com/alcon-smartcataract-study-shows-enhanced-time-savings-during-cataract-surgery/
    4- https://www.medicaldesignandoutsourcing.com/doj-subpoenas-philips-over-respironics-recall-ceo-addresses-investigation/
    3 - https://www.massdevice.com/abbott-launches-upgraded-digital-health-app-for-neurostimulation/
    More Abbott news today... https://www.massdevice.com/abbott-announces-u-s-launch-of-amplatzer-steerable-delivery-sheath-for-amulet-device/
    2 - https://www.massdevice.com/ge-healthcare-medtronic-to-collaborate-on-improving-outpatient-care/
    1 - https://www.massdevice.com/acutus-medical-sells-left-heart-access-portfolio-to-medtronic-in-50m-deal/
    1 hr 14 min
  • DTW - Hear how Shockwave and LimFlow are taking the fight to peripheral vascular diseases
    In this episode, we’ll talk to two of the more innovative companies in the peripheral vascular space – Shockwave Medical and LimFlow – about how they’re helping to treat people who previously had few or zero options.
    This episode is brought to you by Confluent Medical.
    LimFlow CEO Dan Rose walked us through his decision to build his Medtech career in Europe. He also talked about LimFlow’s unique approach to using veins as a route to deliver blood to limbs rather than return blood to the heart.
    Our second interview is with Doug Godshall, CEO and President of Shockwave Medical. Godshall admittedly came to medtech later in his career, but he’s taken on some of its most serious and intractable problems, first as CEO of HeartWare and now Shockwave Medical.
    You can learn more about Shockwave here
    https://shockwavemedical.com/about/our-story/
    and LimFlow here.
    https://limflow.com/
    We’ll also have Chris Newmarker delivering his Newmarker’s Newsmakers including news from Philips, Johnson & Johnson MedTech, Natus Medical, Amazon Web Services, and Dentsplay Sirona.
    Subscribe to this podcast on all major podcast apps.
    #5 https://www.massdevice.com/philips-has-another-round-of-serious-ventilator-recalls/
    #4 https://www.massdevice.com/johnson-johnson-medtech-is-shopping-for-ma-deals/
    #3 https://www.massdevice.com/archimed-group-to-acquire-natus-medical-for-1-2b/
    #2 https://www.medicaldesignandoutsourcing.com/amazon-web-services-aws-cloud-chief-medical-officer-taha-kass-hout-machine-learning-ai/
    #1 https://www.massdevice.com/dentsply-sirona-sacks-ceo/
    1 hr 50 min
  • DTW -Vapotherm was going to have trouble meeting surging COVID-19 demands, then Viant stepped in
    In this week’s episode, we interview Joe Army, CEO of Vapotherm, and Alton Shader, CEO of Viant. First. We’ll follow Army’s heartful move into Medtech, which includes his current role as CEO of Vapotherm, maker of the high flow nasal cannula that proved to be a highly effective tool to treat patients hospitalized with COVID-19. We’ll later learn that Vapotherm’s ability to supply hospitals with this life-saving technology was in doubt due to labor shortages. But Shader details how the contract manufacturer stepped in to immediately help with Vapotherm’s dilemma. The interview is a taste of the discussion Vapotherm and Viant will lead at DeviceTalks Boston on May 10. Go to devicetalks.com to register.
    We also bring in former Johnson & Johnson executive Peter Stebbins to tell us about his upcoming interview with Frank Doyle III, dean of Harvard’s John A. Paulson School of Engineering and Applied Sciences. Doyle will be our keynote interview subject on the morning of May 10 at DeviceTalks Boston.
    Stebbins also provides his experience and insights to this week’s Newmarker’s Newsmakers including news from Medtronic, Masimo, Boston Scientific, GE Healthcare and FitBit.
    #5 https://www.medicaldesignandoutsourcing.com/medtronics-ceo-would-like-to-put-the-tech-in-medtech/
    #4 https://www.massdevice.com/masimo-completes-acquisition-of-sound-united/
    #3 https://www.massdevice.com/boston-scientific-wins-fda-approval-for-imaged-guided-software-for-dbs-therapy/
    #2 https://www.massdevice.com/ge-healthcare-elekta-collaborate-to-expand-precision-radiation-therapy-access/
    #1 https://www.massdevice.com/fda-clears-fitbit-ppg-algorithm-to-detect-afib/
    1 hr 22 min
  • STRYKERTALKS - Acute Care’s Mathieson explains how Vocera fits into Stryker’s goal to help nurses
    In this episode of StrykerTalks, Jessica Mathieson, vice president and general manager of the Acute Care, recounts her unusual path into the medical device industry, giving advice to others interested in making the transition. The conversation then delves into an unassuming – but critical – piece of medical equipment – the hospital bed where most patient-healthcare interaction takes place. Later in the interview, Mathieson will talk about Stryker’s work to provide new technologies that help healthcare workers handle their increasing stress loads; technologies that incorporate technology from the recently acquired Vocera. Also, how is Stryker sharing risk with hospitals to increase patient safety?
    28 min
  • DTW - Think you know what Penumbra may look like in five years? CEO Elsesser’s vision might surprise
    In this episode, Penumbra CEO Adam Elsesser shares why he left a successful law career to become CEO of a medical device startup. After selling that company to Boston Scientific, Elsesser and his co-founders started Penumbra, which has steadily built businesses in stroke and vascular businesses. But Penumbra’s biggest business may be an immersive VR technology system that’s able to improve mental health.
    This episode is sponsored by TE Connectivity.
    Executive Editor Chris Newmarker brings his top stories of the week. This episode’s Newmarker’s Newsmakers including Ascensia, Senseonics, GE Healthcare, Olympus, DJO, Abbott. We also highlight the biggest news of the quarter coming, including an acquisition by Medtronic.
    Subscribe to this podcast on any major podcast player.
    54 min
  • DTW - Endiatx embarks on fantastic voyage in microrobotics; Embecta CEO intros new diabetes player
    In this episode, we’ll assemble the news team to bring you stories big, small and in the middle. Associate Editor Sean Whooley delivers HUGE results. He interviews CEO Dev Kurdikar and CFO Jake Elguicze, leaders of the newly spun out Embecta, the one-time business of Becton Dickinson that’s now an immediate player in the diabetes space. Later on, Jim Hammerand, managing editor of Medical Design & Outsourcing magazine, interviews Torrey Smith, the CEO and Co-founder of Endiatx, a small company developing microrobots that could someday replace the work of an endoscope. In between we’ll hear the Newmarker’s Newsmakers from Chris Newmarker, executive editor of life sciences. This week’s top stories including new from Philips, Biobeat, Staar Surgical, BD, Embecta and Owens Minor.
    Find the articles here:
    https://www.massdevice.com/government-warns-on-cybersecurity-issues-with-philips-e-alert-mri-monitoring-system/
    https://www.massdevice.com/fda-clears-biobeats-remote-vital-sign-monitoring-system/
    https://www.massdevice.com/staar-surgical-wins-fda-approval-for-evo-visian-implantable-collamer-lens/
    https://www.massdevice.com/bd-completes-spinoff-of-embecta-diabetes-company/
    https://www.massdevice.com/owens-minor-completes-1-6b-acquisition-of-apria/
    To read Jim Hammerand's Medical Design and Outsourcing cover story on Endiatx go here. https://www.medicaldesignandoutsourcing.com/endiatx-pillbot-stomach-cam-swims-torrey-smith/
    Subscribe on all major podcast apps.
    1 hr 4 min
  • IntuitiveTalks – How a new venture group keeps Intuitive’s eyes focused forward on the future
    In this episode of IntuitiveTalks, we take our first look at Intuitive’s Future Forward program, a three-piece initiative to better understand how the company fits best into an evolving healthcare landscale. Our guests are Julian Nikolchev, an experienced medical device entrepreneur and investor who now serves as SVP, Development and Strategy at the Intuitive. Nikolchev led the creation of Intuitive Ventures, a $100 million corporate venture capital program led by our second guest, Oliver Keown, MD, a physician turned investor who is leading the creation of an intriguing portfolio of digital and medical device companies that will help inform Intuitive’s future. You can see Intuitive’s full team and portfolio here. https://ventures.intuitive.com/
    35 min
  • DTWEEKLY - CEO Lebed explains how Ukraine-based CRO is keeping trials running during invasion
    In this episode of the DeviceTalks Weekly Podcast, we speak with Yuriy Lebed, the CEO of Pharmaxi LLC, a CRO based in Kyiv, Urkaine, that works with pharmaceutical and medical device companies across the globe. In an interview from Lviv, Lebed says he was as shocked as many that Russia would invade its neighbor. The attack forced him to relocate with his family to Lviv, in the western part of the country. From there, he’s been able to lead the CRO as it keeps many clinical trials running. He calls the country’s regulators are “heroes” for vowing to process approvals while the capital city is bombed. He also says Pharmaxi is already planning for the future, which includes expanding operations into Poland and working within EU countries. You can find a way to donate to relief efforts for Ukraine here. https://www.forbes.com/advisor/personal-finance/donate-relief-to-ukraine
    35 min